Testing a Tongue Scan to Detect Colorectal Polyps
Part of Cancer, Digestive system clinical trials.
This study tests whether a new tongue-scanning tool called Gixam can help find advanced colorectal polyps in people with negative stool tests. If it works, it might offer a simpler screening option alongside colonoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 84 years old
- You have average risk for colorectal cancer (no personal or family history)
- You are scheduled for a screening colonoscopy at the study site
- You have not had a colonoscopy in the past 9 years (with limited exceptions)
- You have not tested positive on stool-based cancer screening tests in the past 11 months
- You do not have inflammatory bowel disease, hereditary cancer syndromes, or recent tongue/dental issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new test called Gixam that may help find pre-cancerous polyps or colorectal cancer earlier. It is for people who had a positive FIT stool test and are scheduled for a colonoscopy.
This trial tests a new device called Gixam to see if it can help find colorectal cancer in people who recently had a normal FIT test (a stool test for blood). You may be able to join if you are between 45 and 85 years old and are already scheduled for a routine screening colonoscopy.
This trial tests a new tool that looks at gut bacteria to help find colorectal cancer earlier. It's for people who already had a positive result on a standard stool test (FIT) as part of a national screening program.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This study aims to find a better way to screen for stomach and colon cancers. You will be asked to provide a stool sample, and possibly have an endoscopy (a camera test), to see if combined screening can catch cancer early.
This study uses an artificial intelligence model to analyze test results from the fecal immunochemical test (FIT) to help find colon cancer early. You may benefit if you are 50-69 and had a positive FIT result as part of a screening program.
Hear when a new CRC Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.